CNLFF yields 14.90% · PFE yields 6.13%● Live data
📍 CNLFF pulled ahead of the other in Year 1
Combined, CNLFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CNLFF + PFE for your $10,000?
Canlan Ice Sports Corp. engages in the acquisition, development, lease, and operation of multi-purpose recreation and entertainment facilities in North America. The company operates through six segments: Ice/Field Sales and Internal Programming, Restaurant and Lounge Operations, Retail Sports Store Operations, Sponsorship, Space Rental, and Management and Consulting Services. It rents ice or field-time on a contract basis and organizes leagues and tournaments, as well as provides lessons and youth camps; operates restaurants and concession outlets; and operates sports stores that sell hockey, skating, and soccer equipment and apparel. The company also engages in the rental of indoor and exterior space to third party tenants; and manages recreation facilities owned by third parties, as well as offers sponsorship and advertising services. As of December 31, 2021, it owned, leased, and managed 18 facilities in Canada and the United States with 49 ice sheets; 7 indoor turf fields; and 24 multi-sport hard courts and outdoor beach volleyball courts. The company was formerly known as Canlan Investment Corporation and changed its name to Canlan Ice Sports Corp. in 1999. The company was incorporated in 1956 and is headquartered in Burnaby, Canada. Canlan Ice Sports Corp. is a subsidiary of Bartrac Investments Ltd.
Full CNLFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.